MedPath

Albuterol Sulfate

Albuterol Sulfate Inhalation Solution, 0.083% 2.5 mg*/3 ml

Approved
Approval ID

574824f3-51cc-4b94-9c10-e3204d8b19f8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 11, 2021

Manufacturers
FDA

Nephron Pharmaceuticals Corporation

DUNS: 079160190

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Albuterol Sulfate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0487-9501
Application NumberANDA074880
Product Classification
M
Marketing Category
C73584
G
Generic Name
Albuterol Sulfate
Product Specifications
Route of AdministrationRESPIRATORY (INHALATION)
Effective DateJanuary 11, 2021
FDA Product Classification

INGREDIENTS (4)

WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
SULFURIC ACIDInactive
Code: O40UQP6WCF
Classification: IACT
ALBUTEROL SULFATEActive
Quantity: 2.5 mg in 3 mL
Code: 021SEF3731
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Albuterol Sulfate - FDA Drug Approval Details